News TagCloud
- Academia
- Agreement
- Agreements
- Board
- Drug
- EBIT
- European
- Genzyme
- Half
- Lonza
- Management
- Manufacturing
- Medical
- Novartis
- Novozymes
- Performance
- Phase
- QIAGEN
- Quarter
- RARE
- Results
- Roche
- Round
- Siegfried
- Straumann
- Syngenta
- Third
- acute
- announces
- data
- disease
- first
- growth
- half
- hearing
- holding
- loss
- million
- mondoBIOTECH
- named
- patients
- reports
- results
- revenues
- sensorineural
- show
- significantly
- stable
- treatment
- trial
BioValley News
Life Technologies Launches Asia Distribution Center in Singapore
SINGAPORE - US-based Life Technologies Corporation (Nasdaq: LIFE), a provider of innovative life science solutions, announced today that it has launched a regional distribution hub in Singapore to address strong customer demand...[more]
Press Releases Back to previous page 23 February 2011 GE Healthcare Expands Mobile Access to Electronic Medical Records
ORLANDO – General Electric, an industry leader in the adoption of mobile technology, demonstrated the extension of its healthcare IT portfolio to mobile devices and tablet computing at this week’s Health Information Management...[more]
DSM completes acquisition of Martek; adding new Nutrition growth platform
Heerlen, NL - Royal DSM N.V. (NYSE Euronext: DSM KON), the global Life Sciences and Materials Sciences company, today announces that it has successfully completed the acquisition of Martek Biosciences Corporation.[more]
GE Healthcare Optima MR430s 1.5T Specialty Scanner Receives FDA Clearance
Improves patient comfort because only targeted anatomy needs to be inside the scanner[more]
Farewell Symposium for Andreas Engel
Andreas Engel, Professor for Structural Biology and former Chairman of the Biozentrum, retired from service to the Biozentrum and became Professor emeritus in October 2010. On February 11th, 2011, the Biozentrum bade farewell to...[more]
Transgene Announces the Termination by Roche of the License Agreement on TG4001/RG3484 for the Treatment of Diseases Caused by the Human Papilloma Virus (“HPV”)
Parc d’Innovation, Illkirch (France) – Transgene (Transgene (NYSE Euronext Paris: FR0005175080)) announces the termination by Roche (SIX: RO, ROG; OTCQX: RHHBY) of the 2007 agreement under which Transgene granted Roche exclusive...[more]
Novartis to commence subsequent offering period for Genoptix, Inc.
Basel - Novartis announced that the initial offering period of its previously announced cash tender offer to purchase all outstanding shares of common stock of Genoptix, Inc. (NASDAQ: GXDX) at USD 25.00 per share in cash has been...[more]
Agilent Technologies' NMR Spectrometer Chosen by Harvard Medical School Laboratory for Biomolecular Applications
SANTA CLARA, Calif. - Agilent Technologies Inc. (NYSE: A) today announced that Harvard Medical School has selected Agilent's 700-MHz Ultra-High Field Nuclear Magnetic Resonance (NMR) spectrometer for biomolecular research...[more]
Thermo Fisher Scientific Signs Agreements to Sell Athena Diagnostics and Lancaster Laboratories Businesses also stock buy back
Thermo Fisher Scientific Signs Agreements to Sell Athena Diagnostics and Lancaster Laboratories Businesses for a Total of $940 Million. Also Announces New $750 Million Authorization to Buy Back its Common Stock[more]
New NICE Guideline Places Child And Young Person Food Allergy Management In The Hands Of GP's And Other Healthcare Professionals In Primary Care And The Community
LONDON - The first guideline for food allergy in children and young people issued by the National Institute for health and Clinical Excellence (NICE) recommends the routine use of allergy testing by Specific IgE blood tests or,...[more]


